¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦42Â÷ 2023³âµµ ´ëÇѽŰæ°úÇÐȸ Ãß°èÇмú´ëȸ DAY 2 : 2023-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦42Â÷ 2023³âµµ ´ëÇѽŰæ°úÇÐȸ Ãß°èÇмú´ëȸ DAY 2 : 2023-11-11
±³À°ÀÏÀÚ : 2023-11-11
±³À°Àå¼Ò : ¼­¿ï ½ºÀ§½º±×·£µå È£ÅÚ ÄÁº¥¼Ç¼¾ÅÍ 3F Emerald Hall A,B , 4F Convention Hall A,B,C

±³À°ÁÖÁ¦ : Á¦42Â÷ 2023³âµµ ´ëÇѽŰæ°úÇÐȸ Ãß°èÇмú´ëȸ DAY 2

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
´ã´çÀÚ : ´ëÇѽŰæ°úÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-737-6530  

À̸ÞÀÏ : kna@neuro.or.kr

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 22 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 160,000¿ø  

ºñ°í »çÀüµî·Ïºñ: Á¤È¸¿ø- Àü¹®ÀÇ 10¸¸¿ø, ÀüÀÓÀÇ,±ºº¹¹«- 6¸¸¿ø, ÁØȸ¿ø- Àü°øÀÇ 6¸¸¿ø, ºñȸ¿ø- Ÿ°ú 16¸¸¿ø, ÇDZ³À°ÀÚ(¿¬±¸¿ø µî) 8¸¸¿ø, ÀÇ°ú´ëÇРȤÀº ÀÇÀü¿ø»ý 1¸¸¿ø ÇöÀåµî·Ïºñ: Á¤È¸¿ø- Àü¹®ÀÇ 12¸¸¿ø, ÀüÀÓÀÇ,±ºº¹¹«- 8¸¸¿ø, ÁØȸ¿ø- Àü°øÀÇ 8¸¸¿ø, ºñȸ¿ø- Ÿ°ú 16¸¸¿ø, ÇDZ³À°ÀÚ 8¸¸¿ø, ÀÇ°ú´ëÇРȤÀº ÀÇÀü¿ø»ý 2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 08:40~09:00 Clinical- anatomical syndromes of posterior circulation stroke: An overview ±èÁ¾¼º(°­¸ª¾Æ»êº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 09:00~09:20 Summary of clinical trial results of EVT in acute basilar occlusion and suggested indication À̹οì(ÇѸ²´ë¼º½Éº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 09:20~09:40 Improving outcome of EVT in acute basilar occlusion– specific considerations ±èÁß±¸(Á¦Áִ뺴¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall A (4F) 09:40~09:50 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 08:40~09:00 Myasthenia gravis: clinical features and diagnosis ¼®Èï¿­(°è¸í´ëµ¿»êÀÇ·á¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 09:00~09:20 Pathogenesis of myasthenia gravis Á¤ÇýÀ±(¿¬¼¼´ë¿ëÀμ¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 09:20~09:40 New targeted therapies in myasthenia gravis ±èÇöÁø(¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall B (4F) 09:40~09:50 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 08:40~09:00 Overview of vestibular system ÀÌÅ°æ(¼øõÇâ´ëºÎõº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 09:00~09:20 Cognition and vestibular system ¿À¼±¿µ(ÀüºÏ´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 09:20~09:40 Autonomic nervous system and vestibular system À̼±¿í(°í·Á´ë¾È¾Ïº´¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall C (4F) 09:40~09:50 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 10:00~10:25 Case-Based Learning: ÀÌ»ó¿îµ¿ ½ÅÁ¤È¯(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 10:25~10:50 Case-Based Learning:½Å°æÀ̾Ȱú ÀÌÀͼº(¼øõÇâ´ëºÎõº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 10:50~11:15 Case-Based Learning:½Å°æÁßȯÀÚÀÇÇÐ ¾È¼ºÈ£(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall A (4F) 11:15~11:40 Case-Based Learning:³úÀüÁõ ±è°æ¹Î(¿¬¼¼´ë¼¼ºê¶õ½ºº´¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall A (4F) 11:40~12:00 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:00~10:15 Updates on Medications for Neurologist: Stroke Á¤¼ö(ÇѾç´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:15~10:30 Updates on Medications for Neurologist:Neuromuscular/motor neuron disorders ¿À¼ºÀÏ(°æÈñ´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:30~10:45 Updates on Medications for Neurologist:Epilepsy/Sleep À±ÁöÀº(¼øõÇâ´ëºÎõº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 10:45~11:00 Updates on Medications for Neurologist:Multiple sclerosis/other CNS demyelinating diseases ±èÁöÀº(ÀÌÈ­ÀÇ´ë¼­¿ïº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 11:00~11:15 Updates on Medications for Neurologist:Dementia ±è¿¹½Å(°­¿ø´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 11:15~11:30 Updates on Medications for Neurologist:Movement À̸íÁØ(°­¿ø´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 11:30~11:45 Updates on Medications for Neurologist:Headache ¹è´ë¿õ(°¡Å縯´ë¼ººó¼¾Æ®º´¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall B (4F) 11:45~12:00 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 10:00~10:30 Neurobiological mechanism of neuropathic pain ¿À¼®¹è(¼­¿ï´ëÇб³ Ä¡ÀÇÇдëÇпø »ý¸®Çб³½Ç)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 10:30~11:00 Psychosocial impact of neuropathic pain ÃÖ±³¹Î(¼øõÇâ´ëõ¾Èº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 11:00~11:30 Pharmacological management of neuropathic pain ¼­¹üõ(°­ºÏ»ï¼ºº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 11:30~12:00 Neuromodulation for neuropathic pain À¯¿ëÀç(¼­¿ï´ëº´¿ø ¸¶ÃëÅëÁõÀÇÇаú)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 10:00~10:30 Why treat insomnia and what is CBT-I? Donn Posner(Stanford University)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 10:30~11:00 CBT-I: Beyond what we know - "known unknowns" Michael Perlis(University of Pennsylvania)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 11:00~11:30 Insomnia medication : Safety, Efficacy, and Placebo effect Michael Perlis(University of Pennsylvania)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 11:30~11:50 Adaptation of CBT-I in Older Adults ±èÇö(Columbia University)

Åä·Ð 11¿ù 11ÀÏ Emerald Hall A (3F) 11:50~12:00 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 14:10~14:30 Neuropalliative care_a practical guide for the neurologist À¯¼ö¿¬(°è¸í´ëµ¿»êÀÇ·á¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 14:30~15:00 ½Å°æ°ú ȯÀÚ¸¦ À§ÇÑ ÀçÅÃÀÇ·á¿Í ¿ÏÈ­ÀÇ·á À̼±¿µ(¼­¿ï´ëº´¿ø ÀçÅÃÀÇ·áŬ¸®´Ð)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 15:00~15:20 Neuropalliative care for acute neurologic illness ±è¿µ¼ö(°æ»ó´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (4F) 15:20~15:40 Neuropalliative care for progressive neurologic disease ¼­Áö¿ø(±¹¸³Áß¾ÓÀÇ·á¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall B (4F) 15:40~15:50 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 14:10~14:40 ÀÎÁöÀå¾Ö ȯÀÚ¸¦ À§ÇÑ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í ¹Ì·¡ ¿Õ¹ÎÁ¤(·Î¾Æ½Å°æ°úÀÇ¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 14:40~15:10 TCD¸¦ È°¿ëÇÑ µÎÅëÀÇ Áø´Ü°ú Ä¡·á Á¤Áø»ó(Á¤Áø»ó½Å°æ°úÀÇ¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall C (4F) 15:10~15:20 Q&A ()

ÈÞ½Ä 11¿ù 11ÀÏ Convention Hall C (4F) 15:20~15:30 Break ()

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 15:30~16:00 ÃÊÀ½Æĸ¦ È°¿ëÇÑ ÅëÁõ Ä¡·á Çѹü±â(¿¬¼¼½Å°æ°úÀÇ¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall C (4F) 16:00~16:30 EMG/NCS¸¦ ÀÌ¿ëÇÑ ¼ö¼ú Àü ½Å°æ°ú ÇùÁø Áø·áÀÇ ¿ªÇÒ ±è±¤±¹(±è±¤±¹½Å°æ°úÀÇ¿ø)

Åä·Ð 11¿ù 11ÀÏ Convention Hall C (4F) 16:30~16:40 Q&A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 13:00~13:25 ¼ö¸é´Ù¿ø°Ë»ç ÀûÀÀÁõ ¹× Áغñ»çÇ× ¹ÚÀ±°æ(ÇϳªÀ̺ñÀÎÈÄ°úº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 13:25~13:55 Sleep staging and arousals in adults ½ÅÇý¸²(´Ü±¹´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 13:55~14:25 Scoring rules for respiratory events ±èµ¿¿±(ÀÌÈ­ÀÇ´ë¼­¿ïº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 14:25~14:50 Scoring rules for movement events/ Parasomnia Ȳ¼ºÀº(ÀÌÈ­ÀÇ´ë¸ñµ¿º´¿ø)

Åä·Ð 11¿ù 11ÀÏ Emerald Hall A (3F) 14:50~15:00 Q & A ()

ÈÞ½Ä 11¿ù 11ÀÏ Emerald Hall A (3F) 15:00~15:10 Break ()

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 15:10~15:40 CPAP titration ¹× interpretation ¾çÅ¿ø(â¿ø°æ»ó±¹¸³´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 15:40~16:10 MSLT °Ë»ç ¹æ¹ý ÀÌÇØ¿Í Æǵ¶ ÁÖº´¾ï(¼øõÇâ´ëÇб³º´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 16:10~16:35 ¼ö¸é´Ù¿ø°Ë»çÁö ÀÛ¼º ¹× Çؼ® ÇѼöÇö(Á߾Ӵ뺴¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall A (3F) 16:35~17:00 ¼ö¸é´Ù¿ø°Ë»ç Áß ¹ß»ýÇÏ´Â ÀÀ±Þ»óȲ ÀÌ¿ìÁø(ºÐ´ç¼­¿ï´ëº´¿ø)

Åä·Ð 11¿ù 11ÀÏ Emerald Hall A (3F) 17:00~17:10 Q & A ()

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall B (3F) 14:30~15:20 ÀÇ·áºÐÀï»ç·Ê ÀÌ¿µÈ£(¹ý¹«¹ýÀÎ ÀǼº) Çʼö

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall B (3F) 15:20~15:50 ¸¶¾à·ù ¾ÈÀü»ç¿ë ±âÁØ ¹Î¾ç±â(ÇѸ²´ë°­³²¼º½Éº´¿ø) Çʼö

±³À°½Ã°£ 11¿ù 11ÀÏ Emerald Hall B (3F) 15:50~16:30 ¸¶¾à·ùÅëÇÕ°ü¸®½Ã½ºÅÛÀ» ÅëÇÑ ¸¶¾à·ù ¾ÈÀü°ü¸® ¹ÚÁÖ¿¬(Çѱ¹ÀǾàÇ°¾ÈÀü°ü¸®¿ø ¸¶¾à·ùÁ¦µµÁö¿øÆÀ) Çʼö

±³À°½Ã°£ 11¿ù 11ÀÏ Convention Hall B (3F) 16:30~17:30 Ä¡¸ÅƯº°µî±Þ ±³À° ±èÈñÁø(ÇѾç´ëº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦42Â÷ 2023³âµµ ´ëÇѽŰæ°úÇÐȸ Ãß°èÇмú´ëȸ DAY 2 : 2023-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦16ȸ Èñ±Í½Å°æ±ÙÀ°°èÁúȯ¡¤È£ÈíÀçÈ° ½ÉÆ÷Áö¾ö : 2023-11-11
´ÙÀ½±Û 2023 Çѱ¹ÀÇÁö¡¤º¸Á¶±âÇÐȸ Ãß°èÇмú´ëȸ : 2023-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 27 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 47 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷